#CARTcelltherapy
Mayo Clinic researchers report dramatic functional improvements in SPS patients using CAR-T cell therapy, with some returning to work and daily activities.
#science #stiffpersonsyndrome #CARTcelltherapy
CAR-T Therapy Shows Promise in Stiff Person Syndrome Trial
6ic.com
November 12, 2026 at 8:45 PM
While CAR T-cell therapies approved by the Alliance for Cancer Gene Therapy include Kymriah and Yescarta for blood cancers, they struggle with solid tumors and side effects like CRS and ICANS. Complex manufacturing and high costs limit the number of pat…

#CARTCellTherapy #SolidTumors #Immunotherapy
Seven therapies approved for blood cancers
Source: GEN (Genetic Eng News)
realfeedapp.com
November 9, 2026 at 4:40 PM
Armoring #CARTcelltherapy with anti-inflammatory molecules offers new avenues for anti-fibrotic therapies in #ChronicKidneyDisease & other #Fibrosis conditions www.jci.org/articles/vie... @JonEpsteinLab #CellTherapy #CARTCell #TranslationalScience
www.jci.org
October 26, 2026 at 4:36 PM
A welcome step forward for lymphoma patients! A Cincinnati woman has become the first UC Cancer Center patient to receive CAR-T cell therapy as an outpatient, allowing her to recover in the comfort of her own home.

www.wlwt.com/article/univ...

#Lymphoma #CARTCellTherapy #TCSC
Cincinnati woman becomes first UC Cancer Center patient to get therapy as outpatient
A woman battling follicular lymphoma became the first patient at the UC Cancer Center to receive CAR-T cell therapy as an outpatient, a treatment that allowed her to recover at home.
www.wlwt.com
October 28, 2026 at 7:10 AM
Timing matters in multiple myeloma care. Specialists say earlier referral for CAR-T assessment could help eligible patients access treatment before their disease progresses further.

www.cancernetwork.com/view/earlier...

#MultipleMyeloma #CARTCellTherapy #TCSC
Earlier Referral Enables Outpatient Care in Multiple Myeloma | CancerNetwork
Adam D. Cohen, MD, director of Myeloma Immunotherapy and professor of medicine at the Hospital of the University of Pennsylvania, asked whether patients lose the chance to receive CAR T-cell therapy i...
www.cancernetwork.com
October 20, 2026 at 9:08 AM
All seven participants in a small Phase 2 trial experienced clinically meaningful improvements, and six remained off immunosuppressants at their latest follow-up: https://bit.ly/4ykYMT8

#MyastheniaGravis #MGFA #CARTCellTherapy #MyastheniaGravisNews #Bionews
October 12, 2026 at 7:03 PM
Together, we’ll explore:

▪️ Who these treatments are for

▪️ What to expect before, during, and after treatment

▪️ How side effects are monitored and managed

💬 Join us now to hear more about it! It’s free:

give.cancergrace.org/event/blood-...

#Lymphoma #CARTCellTherapy #BloodCancer #GRACE
Blood Cancers OncTalk 2026
{{MetaTags.description}}
give.cancergrace.org
October 10, 2026 at 4:34 PM
#CARTCellTherapy is moving beyond #Cancer.

This review explores its potential across #Autoimmune, aging-related, and #InfectiousDiseases, focusing on targeted cell depletion, immune remodeling, clinical advances, and translational challenges.

#STTT #OpenAccess: doi.org/10.1038/s413...
October 4, 2026 at 3:30 PM
After CAR T-cell therapy, what changes should you report? Linda Ramsdell, MSN, FNP-BC, OCN, discusses follow-up health. Watch or read:

bmtinfonet.org/video/protec...

#CARTCellTherapy
October 3, 2026 at 2:29 PM
🔬 NEW: CAR T cells engineered to target mutant calreticulin successfully depleted disease-driving cells in myelofibrosis mod…

#Calreticulinmutation #CARTcelltherapy #Myelofibrosis #Precisionimmunotherapy #Translationalresearch

#Calreticulinmutation #CARTcelltherapy #Myelofibrosis #Precisionimmu…
CAR T therapy targets myelofibrosis mutations
🔬 NEW: CAR T cells engineered to target mutant calreticulin successfully depleted disease-driving cells in myelofibrosis mod… #Calreticulinmutation #CARTcelltherapy #Myelofibrosis #Precisionimmunotherapy #Translationalresearch
news.gmj.ge
September 22, 2026 at 7:26 AM
Is CAR T-cell therapy 'enough,' or does the patient still need a transplant after? Two SOHO experts hash it out. Full episode of SOHO Spotlight 👇
soho.click/soho-spotlig...
#SOHOSpotlight #HematologicOncology #CARTCellTherapy #ALL
September 18, 2026 at 5:17 PM
CAR T erased rheumatoid arthritis in 3 patients who had exhausted all other options #ClinicalTrial #CarTCellTherapy #AutoimmuneDisease
CAR T erased rheumatoid arthritis in 3 patients who had exhausted all other options
Three patients with severe rheumatoid arthritis that had resisted every available treatment are now in drug-free remission after a single infusion of CAR T cells — a therapy developed for cancer — in
www.martincid.com
August 31, 2026 at 9:45 AM
A cancer treatment could have a remarkable second life. CAR T-cell therapy dramatically reduced severe rheumatoid arthritis in a small trial, with three of six patients achieving medication-free remission.

www.sciencedaily.com/releases/202...

#CARTCellTherapy #CancerResearch #MedicalResearch #TCSC
A cancer therapy put severe rheumatoid arthritis into remission
CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free remission. The treatmen...
www.sciencedaily.com
August 30, 2026 at 7:06 AM
Another step forward for CAR T-cell therapy in solid tumours. The FDA has cleared ADI-212 for clinical testing in advanced prostate cancer, allowing a Phase 1/2 trial of the off-the-shelf treatment to move ahead.

www.targetedonc.com/view/fda-cle...

#Prostate #CARTCellTherapy #ClinicalTrials #TCSC
FDA Clears IND for ADI-212, a PSMA-Targeted CAR T, in mCRPC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
FDA clears IND for ADI-212, an off-the-shelf PSMA-targeted gamma-delta CAR T for metastatic castration-resistant prostate cancer, as phase 1/2 trial readies 2026 enrollment.
www.targetedonc.com
August 30, 2026 at 7:09 AM
A first-of-its-kind clinical trial found that #CARTCellTherapy substantially reduced disease activity in six patients with severe #RheumatoidArthritis, with three requiring no medication by the end of the observation period.
#AutoimmuneDisease #CellTherapy
Cell therapy successful in treating severe rheumatoid arthritis – BioNews Central
A first-of-its-kind clinical trial found that CAR T-cell therapy substantially reduced disease activity in six patients with severe rheumatoid arthritis, with three requiring no medication by the end of the observation period. ...
sbee.link
August 27, 2026 at 11:55 PM
August 25, 2026 at 12:45 AM
August 20, 2026 at 4:32 AM
🩸 Facts about Diffuse Large B-Cell Lymphoma:

Identifying patients for pola-R-CHP, managing limited-stage and high-risk DLBCL, and the role of CD19 CAR T-cell therapy in early relapsed or refractory disease.

#DLBCL #Lymphoma #Hematology #CARTCellTherapy #MedEd #ClinicalHematology #HemeHub
August 20, 2026 at 4:30 AM
🧬 Você sabia que o Brasil tem feito avanços significativos no desenvolvimento de terapias com células CAR-T? Essa tecnologia revolucionária reprograma as células de defesa do próprio paciente para combater o câncer.

Fique por dentro ➡️ www.linkedin.com/posts/ctc-us...
#cartcelltherapy #cienciabrasileira #inovacaoemsaude #hemocentrorp #ctcusp | CTC USP
A ciência brasileira na vanguarda da inovação em saúde! 🟢 🟡 ✨ 🧬 Você sabia que o Brasil tem feito avanços significativos no desenvolvimento de terapias com células CAR-T? Essa tecnologia revolucionár...
www.linkedin.com
March 9, 2026 at 5:43 PM
Could CAR-T therapy finally become more effective against solid tumours? USC researchers have developed a technique using focused ultrasound to give tumours a target that engineered immune cells can recognise and attack.

viterbischool.usc.edu/news/2026/08...

#CARTCellTherapy #Immunotherapy #TCSC
A new way to help CAR-T cells fight solid tumors could change cancer treatment - USC Viterbi | School of Engineering
USC researchers developed a technique that uses focused ultrasound to temporarily "light up" solid tumors, giving cancer-fighting immune cells a target they can finally recognize.
viterbischool.usc.edu
August 14, 2026 at 8:15 AM
Smarter cancer-fighting immune cells could be on the horizon. USC engineers have developed a new CAR-T system designed to target solid tumours more precisely while reducing damage to healthy tissue. viterbischool.usc.edu/news/2026/06...

#CARTCellTherapy #Immunotherapy #CancerResearch #TCSC
Smarter, Safer Cancer Fighters - USC Viterbi | School of Engineering
USC engineers have developed a new CAR T-cell therapy that can adapt to almost any solid tumor, attack with precision and spare healthy tissue.
viterbischool.usc.edu
June 17, 2026 at 10:29 AM
REVIEW: Aging and immunity: the age-old tango
by Fernández Maestre et al. @corina-amor.bsky.social‬ @cshlaboratory.bsky.social‬
➡️ https://tinyurl.com/gd352644
##aging #senescence #cancer #immuneregulation #antiaging #immunotherapy #CancerImmunotherapy #Inflammaging #CARTCellTherapy #CART
August 8, 2025 at 3:29 PM
This study developed a #PrognosticScoringSystem for severe #CRS in Chinese B ALL patients receiving #AntiCD19 #CARTCellTherapy, integrating #clinical and laboratory parameters to support early identification and management. #medsky

#OpenAccess: doi.org/10.1007/s115...
April 13, 2026 at 7:15 AM